Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors

Fasting or Non-fasting Lipids for Atherosclerotic Cardiovascular Disease Risk Assessment and Treatment?

(2018) Faisal Rahman et al.   Current Atherosclerosis Reports

Immunology of Major Depression

(2017) Norbert Müller   NEUROIMMUNOMODULATION

Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders

(2016) Viktoria Johansson et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression

(2016) D R Goldsmith et al.   MOLECULAR PSYCHIATRY

Schizophrenia risk from complex variation of complement component 4

(2016) Aswin Sekar et al.   NATURE

Inflammatory evidence for the psychosis continuum model

(2016) Ragni H. Mørch et al.   PSYCHONEUROENDOCRINOLOGY

Is it time for immunopsychiatry in psychotic disorders?

(2016) Marion Leboyer et al.   PSYCHOPHARMACOLOGY

Somatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span

(2016) Ingrid Dieset et al.   SCHIZOPHRENIA BULLETIN

Neuroimmune biomarkers in schizophrenia

(2016) Jakub Tomasik et al.   SCHIZOPHRENIA RESEARCH

Plasma Levels of Soluble Interleukin-2 Receptor αSignificance

(2015) Peter Durda et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Inflammation and metabolic changes in first episode psychosis: Preliminary results from a longitudinal study

(2015) Alice Russell et al.   BRAIN BEHAVIOR AND IMMUNITY

The Innate Immune Receptor CD14 Mediates Lymphocyte Migration in EAE

(2015) Ramona Halmer et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Inflammatory cytokines as biomarkers in heart failure

(2015) Thor Ueland et al.   CLINICA CHIMICA ACTA

CD14 is a key organizer of microglial responses to CNS infection and injury

(2015) Hana Janova et al.   GLIA

Structural and functional features of central nervous system lymphatic vessels

(2015) Antoine Louveau et al.   NATURE

The Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary Syndromes

(2015) E. Idzkowska et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls

(2015) Sigrun Hope et al.   SCHIZOPHRENIA RESEARCH

Neuroinflammation and white matter pathology in schizophrenia: systematic review

(2015) Souhel Najjar et al.   SCHIZOPHRENIA RESEARCH

Obesity, inflammation, and the gut microbiota

(2015) Amanda J Cox et al.   Lancet Diabetes & Endocrinology

Elevated Levels of Monocyte Activation Markers Are Associated With Subclinical Atherosclerosis in Men With and Those Without HIV Infection

(2014) Rebeccah A. McKibben et al.   JOURNAL OF INFECTIOUS DISEASES

ALCAM and CD6 — multiple sclerosis risk factors

(2014) M. Wagner et al.   JOURNAL OF NEUROIMMUNOLOGY

MIF: Mood Improving/Inhibiting Factor?

(2014) Joshua Bloom et al.   Journal of Neuroinflammation

Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci

(2014) O A Andreassen et al.   MOLECULAR PSYCHIATRY

Biological insights from 108 schizophrenia-associated genetic loci

(2014)   NATURE

Increased Mortality in Schizophrenia Due to Cardiovascular Disease – A Non-Systematic Review of Epidemiology, Possible Causes, and Interventions

(2014) Petter Andreas Ringen et al.   Frontiers in Psychiatry

Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors

(2013) Ole A. Andreassen et al.   AMERICAN JOURNAL OF HUMAN GENETICS

The Cytokine Model of Schizophrenia: Emerging Therapeutic Strategies

(2013) Ragy R. Girgis et al.   BIOLOGICAL PSYCHIATRY

Autoimmunity, Inflammation, and Psychosis: A Search for Peripheral Markers

(2013) Veerle Bergink et al.   BIOLOGICAL PSYCHIATRY

Pathway analysis of a genome-wide association study in schizophrenia

(2013) Young Ho Lee et al.   GENE

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder

(2013) Sigrun Hope et al.   SCHIZOPHRENIA RESEARCH

Comorbidities and Mortality in Bipolar Disorder

(2013) Casey Crump et al.   JAMA Psychiatry

Life expectancy and cardiovascular mortality in persons with schizophrenia

(2012) Thomas M. Laursen et al.   CURRENT OPINION IN PSYCHIATRY

Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein

(2012) Ingrid Dieset et al.   SCHIZOPHRENIA RESEARCH

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia

(2011) Sigrun Hope et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Activated Leukocyte Cell Adhesion Molecule and Prognosis in Acute Ischemic Stroke

(2011) Linda Smedbakken et al.   STROKE

Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies

(2010) Alan S. Brown et al.   AMERICAN JOURNAL OF PSYCHIATRY

Autoimmune diseases, bipolar disorder, and non-affective psychosis

(2010) William W Eaton et al.   BIPOLAR DISORDERS

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor

(2009) Sigrun Hope et al.   BIPOLAR DISORDERS

Neurocognitive Dysfunction in Bipolar and Schizophrenia Spectrum Disorders Depends on History of Psychosis Rather Than Diagnostic Group

(2009) C. Simonsen et al.   SCHIZOPHRENIA BULLETIN